Intra-cellular therapies to present at the 45th annual goldman sachs global healthcare conference

New york, june 10, 2024 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to present at the 45th annual goldman sachs global healthcare conference on tuesday, june 11, 2024 at 10:00 a.m. et in miami, fl.
ITCI Ratings Summary
ITCI Quant Ranking